Resounding success in Dubai

Dubai/Malsfeld – Dr. Schumacher GmbH has been a regular guest at Arab Health for more than a decade now. With over 4,150 exhibitors, the international event, held this year from 28th to 31st January in Dubai, is one of the world’s largest health trade fairs. This year, Dr. Schumacher GmbH managed to improve on the success of previous years yet again and welcomed a wide variety of trade fair visitors and trading partners from across the MENA region.

The highlight was the presentation of the Dr. Schumacher PREVENT::PRESERVE::PROTECT hygiene levels, which offer simplicity, transparency, safety and a systematic approach to all hygiene measures.
• PREVENT Level: Preventative disinfection measures inhibit the spread of pathogens in general areas such as waiting rooms, hallways and offices.
• PRESERVE Level: There are many factors that increase the risk of infection on the wards and in outpatient areas. Suitable disinfection measures with more stringent requirements for effectiveness protect patients and personnel against additional negative factors.
• PROTECT Level: In isolation areas of medical facilities as well as in outbreak situations, the focus for hygiene is on maximum effectiveness in accordance with the requirements in high-risk areas.

Another focus was on the presentation of ASEPTOMAN FORTE® from the PROTECT hygiene level. The virucidal, ethanol-based hand disinfectant in the ASEPTOMAN® range has a broad spectrum of action with very good skin compatibility.

Over the years, Arab Health has become increasingly important for Dr. Schumacher GmbH. After starting out with a small booth for the first few years, the company has increased its booth area consistently ever since. “We have been using a local booth builder for the realisation of our concept for the last three years. This places us considerably further into the visitors’ focus, which has allowed us to increase the number of conversations with interested visitors by around 20%,” said Michael Pfaffenbach, Head of International Sales. “And it’s not only the quantity, but also the quality of the conversations which is increasing consistently. The positive development in recent years is further encouragement for us to exhibit at Arab Health in the future.”

Fouad Bassil, CEO of Trinity Medical, Beirut: “As exclusive agent for Dr. Schumacher, our company philosophy is offering high quality, high grade, effective, user friendly and economical products, designed to accomplish the highest measure of hygiene and disinfection. The impact of the Arab Health on our business is very positive, because hospitals and health care facilities come to talk to the experts at the Dr. Schumacher booth where clients will get answers to all the questions they have and get to know Dr. Schumacher even better. It is a great event to find what you are looking for in terms of business; see what is new in the medical field and the newest technologies.”
Hence, Dr. Schumacher GmbH draws a thoroughly positive balance overall. The team evening, where the hygiene expert’s trading partners had the opportunity to get to know each other and exchange their experiences, was also a resounding success.

Dr. Schumacher GmbH
For 40 years, Dr. Schumacher GmbH has been one of the leading developers and manufacturers of innovative products for disinfection, hygiene, cleaning, skin care and cosmetics – both for medical applications and end consumers. With more than 1,800 employees in eight sites, the family business, based in Malsfeld, produces cleaning agents and disinfectants for skin, hands, instruments and surfaces. As one of the largest manufacturers of impregnated and dry wipe systems in Europe, Dr. Schumacher GmbH has its own production facilities for non-woven fabric wipe systems and impregnated wipes. A network of distribution partners in about 70 countries emphasises the international focus of the hygiene experts.

Dr. Schumacher GmbH
Roggenfeld 3
D-34323 Malsfeld

Anja Dörnke-Bartling
Phone: +49 5664 9496 2002
presse@schumacher-online.com

This release was published on openPR.